Nicolau Beckmann, PhD, and Sarah-Rebecca Herrmann[email protected]MRIPreclinical lung imaging offers effective evaluation of drug candidatesDrug discovery and development are arduous and costly endeavors, with nine in 10 drug candidates failing to gain approval. Preclinical imaging can help pharmaceutical companies more effectively evaluate drug candidates, in particular for respiratory diseases.January 31, 2021Page 1 of 1Top StoriesMolecular ImagingAmyloid PET scans validated in racially diverse patientsChanges in care plans occurred in 59% of individuals after PET scans.Womens ImagingLimited access to PCPs thwarts mammography screening uptakeUltrasoundPOCUS rules out pulmonary congestion in kidney patientsEconomicsLow-value imaging services part of high Medicare costsDigital X-RayAI helps clinicians identify misplaced endotracheal tubes